Kadmon Holdings Stock Price, News & Analysis (NYSE:KDMN)

$3.69 -0.01 (-0.27 %)
(As of 11/20/2017 04:00 PM ET)
Previous Close$3.70
Today's Range$3.65 - $3.80
52-Week Range$2.05 - $6.00
Volume210,186 shs
Average Volume279,727 shs
Market Capitalization$290.98 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Kadmon Holdings (NYSE:KDMN)

Kadmon Holdings logoKadmon Holdings, Inc. is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. Its product pipeline consists of KD025, Tesevatinib and KD034. The Company's other products include Ribasphere RibaPak, Ribasphere, Qsymia, Tetrabenazine and Valganciclovir. KD025 is an orally available, selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a molecular target in multiple autoimmune, fibrotic and neurodegenerative diseases. Tesevatinib is an oral tyrosine kinase inhibitor (TKI) designed to block key molecular drivers of tumor growth, metastases and drug resistance. KD034 is the Company's portfolio of enhanced formulations of trientine hydrochloride for the treatment of Wilson's disease.


Industry, Sector and Symbol:
  • Industry: Biopharmaceuticals
  • Sub-Industry: N/A
  • Sector: Healthcare
  • Symbol: NYSE:KDMN
  • CUSIP: N/A
  • Web: kadmon.com
Debt:
  • Current Ratio: 1.30%
  • Quick Ratio: 1.29%
Sales & Book Value:
  • Annual Sales: $26.06 million
  • Price / Sales: 11.14
  • Book Value: ($1.41) per share
  • Price / Book: -2.62
Profitability:
  • Trailing EPS: ($1.75)
  • Net Income: ($208,750,000.00)
  • Net Margins: -555.91%
  • Return on Assets: -124.91%
Misc:
  • Employees: 118
  • Outstanding Shares: 78,640,000
 

Frequently Asked Questions for Kadmon Holdings (NYSE:KDMN)

What is Kadmon Holdings' stock symbol?

Kadmon Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "KDMN."

How were Kadmon Holdings' earnings last quarter?

Kadmon Holdings, Inc. (NYSE:KDMN) announced its quarterly earnings results on Thursday, November, 9th. The company reported ($0.42) earnings per share for the quarter, missing analysts' consensus estimates of ($0.38) by $0.04. The company had revenue of $2.28 million for the quarter, compared to analyst estimates of $5.69 million. Kadmon Holdings's revenue for the quarter was down 60.0% compared to the same quarter last year. During the same quarter last year, the company earned ($4.24) EPS. View Kadmon Holdings' Earnings History.

Where is Kadmon Holdings' stock going? Where will Kadmon Holdings' stock price be in 2017?

5 analysts have issued 1 year target prices for Kadmon Holdings' stock. Their predictions range from $3.00 to $25.00. On average, they anticipate Kadmon Holdings' share price to reach $9.75 in the next twelve months. View Analyst Ratings for Kadmon Holdings.

Are investors shorting Kadmon Holdings?

Kadmon Holdings saw a decline in short interest in October. As of October 13th, there was short interest totalling 1,298,965 shares, a decline of 35.9% from the September 29th total of 2,026,862 shares. Based on an average trading volume of 654,970 shares, the short-interest ratio is currently 2.0 days. Currently, 2.0% of the company's stock are sold short.

Who are some of Kadmon Holdings' key competitors?

When did Kadmon Holdings IPO?

(KDMN) raised $101 million in an IPO on Wednesday, July 27th 2016. The company issued 5,600,000 shares at a price of $16.00-$20.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers.

Who owns Kadmon Holdings stock?

Kadmon Holdings' stock is owned by a number of of institutional and retail investors. Top institutional investors include GOLDENTREE ASSET MANAGEMENT LP (8.80%), PUISSANCE CROSS-BORDER OPPORTUNITIES IV LLC (5.93%), Sphera Funds Management LTD. (1.40%), Crestline Management LP (0.76%), AE Wealth Management LLC (0.41%) and Wells Fargo & Company MN (0.09%). Company insiders that own Kadmon Holdings stock include Bart M Schwartz, Daniel S Loeb, Eugene Bauer, Goldentree Asset Management Lp, Harlan Waksal, Konstantin Poukalov and Steven N Gordon. View Institutional Ownership Trends for Kadmon Holdings.

Who bought Kadmon Holdings stock? Who is buying Kadmon Holdings stock?

Kadmon Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Sphera Funds Management LTD., Crestline Management LP, AE Wealth Management LLC, Old West Investment Management LLC, Bank of New York Mellon Corp and Wells Fargo & Company MN. Company insiders that have bought Kadmon Holdings stock in the last two years include Bart M Schwartz, Daniel S Loeb, Eugene Bauer, Goldentree Asset Management Lp, Harlan Waksal, Konstantin Poukalov and Steven N Gordon. View Insider Buying and Selling for Kadmon Holdings.

How do I buy Kadmon Holdings stock?

Shares of Kadmon Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Kadmon Holdings' stock price today?

One share of Kadmon Holdings stock can currently be purchased for approximately $3.69.

How big of a company is Kadmon Holdings?

Kadmon Holdings has a market capitalization of $290.98 million and generates $26.06 million in revenue each year. The company earns ($208,750,000.00) in net income (profit) each year or ($1.75) on an earnings per share basis. Kadmon Holdings employs 118 workers across the globe.

How can I contact Kadmon Holdings?

Kadmon Holdings' mailing address is 450 E 29th St, NEW YORK, NY 10016-8367, United States. The company can be reached via phone at +1-212-3086000 or via email at [email protected]


MarketBeat Community Rating for Kadmon Holdings (NYSE KDMN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  160
MarketBeat's community ratings are surveys of what our community members think about Kadmon Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Kadmon Holdings (NYSE:KDMN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 3 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $9.75 (164.23% upside)

Consensus Price Target History for Kadmon Holdings (NYSE:KDMN)

Price Target History for Kadmon Holdings (NYSE:KDMN)

Analysts' Ratings History for Kadmon Holdings (NYSE:KDMN)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/17/2017HC WainwrightReiterated RatingBuy$25.00N/AView Rating Details
10/9/2017WBB SecuritiesDowngradeHold -> Sell$3.00N/AView Rating Details
8/2/2017Piper Jaffray CompaniesSet Price TargetBuy$7.00MediumView Rating Details
3/27/2017Citigroup Inc.Lower Price TargetNeutral$6.00 -> $4.00HighView Rating Details
11/21/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
11/10/2016Jefferies Group LLCReiterated RatingBuy$12.00 -> $10.00N/AView Rating Details
(Data available from 11/20/2015 forward)

Earnings

Earnings History and Estimates Chart for Kadmon Holdings (NYSE:KDMN)

Earnings by Quarter for Kadmon Holdings (NYSE:KDMN)

Earnings History by Quarter for Kadmon Holdings (NYSE KDMN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.38)($0.42)$5.69 million$2.28 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.49)($0.44)$3.46 million$3.00 millionViewN/AView Earnings Details
5/15/2017Q1 2017($0.52)($0.39)$4.25 million$5.60 millionViewN/AView Earnings Details
3/22/2017Q4 2016($0.71)($0.50)$4.50 million$4.28 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.40)($4.23)$3.90 million$5.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Kadmon Holdings (NYSE:KDMN)
Current Year EPS Consensus Estimate: $-1.63 EPS
Next Year EPS Consensus Estimate: $-1.78 EPS

Dividends

Dividend History for Kadmon Holdings (NYSE:KDMN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Kadmon Holdings (NYSE KDMN)

Insider Ownership Percentage: 8.41%
Institutional Ownership Percentage: 27.96%
Insider Trades by Quarter for Kadmon Holdings (NYSE:KDMN)
Institutional Ownership by Quarter for Kadmon Holdings (NYSE:KDMN)

Insider Trades by Quarter for Kadmon Holdings (NYSE KDMN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2017Goldentree Asset Management LpMajor ShareholderSell302,950$2.73$827,053.50View SEC Filing  
8/10/2017Harlan WaksalCEOBuy5,000$2.27$11,350.00View SEC Filing  
8/8/2017Eugene BauerDirectorBuy5,000$2.36$11,800.00View SEC Filing  
8/8/2017Harlan WaksalCEOBuy3,707$2.34$8,674.38View SEC Filing  
8/8/2017Steven N. GordonVPBuy1,000$2.47$2,470.00View SEC Filing  
7/31/2017Goldentree Asset Management LpMajor ShareholderSell349,661$2.60$909,118.60View SEC Filing  
7/11/2017Goldentree Asset Management LpMajor ShareholderSell34,462$3.69$127,164.78View SEC Filing  
6/29/2017Goldentree Asset Management LpMajor ShareholderSell64,375$4.04$260,075.00View SEC Filing  
6/27/2017Goldentree Asset Management LpMajor ShareholderSell108,827$3.69$401,571.63View SEC Filing  
6/26/2017Goldentree Asset Management LpMajor ShareholderSell515,643$3.51$1,809,906.93View SEC Filing  
6/22/2017Goldentree Asset Management LpMajor ShareholderSell767,363$3.50$2,685,770.50View SEC Filing  
3/13/2017Daniel S LoebMajor ShareholderBuy1,488,095$3.36$4,999,999.20View SEC Filing  
11/16/2016Harlan WaksalCEOBuy2,000$6.37$12,740.00View SEC Filing  
11/14/2016Harlan WaksalCEOBuy2,000$6.79$13,580.00View SEC Filing  
11/11/2016Konstantin PoukalovCFOBuy4,000$5.81$23,240.00View SEC Filing  
9/14/2016Daniel S LoebMajor ShareholderBuy19,611$7.79$152,769.69View SEC Filing  
9/13/2016Daniel S LoebMajor ShareholderBuy68,654$8.33$571,887.82View SEC Filing  
9/6/2016Daniel S LoebMajor ShareholderBuy81,781$9.39$767,923.59View SEC Filing  
8/26/2016Daniel S LoebMajor ShareholderBuy32,916$9.98$328,501.68View SEC Filing  
8/22/2016Daniel S LoebMajor ShareholderBuy11,305$10.00$113,050.00View SEC Filing  
8/15/2016Daniel S LoebMajor ShareholderBuy6,010$9.95$59,799.50View SEC Filing  
8/12/2016Daniel S LoebMajor ShareholderBuy87,529$9.98$873,539.42View SEC Filing  
8/5/2016Daniel S LoebMajor ShareholderBuy66,828$9.94$664,270.32View SEC Filing  
8/3/2016Daniel S LoebMajor ShareholderBuy1,431,996$11.35$16,253,154.60View SEC Filing  
8/1/2016Goldentree Asset Management LpMajor ShareholderBuy208,333$12.00$2,499,996.00View SEC Filing  
7/28/2016Bart M SchwartzDirectorBuy2,000$9.77$19,540.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Kadmon Holdings (NYSE KDMN)

Source:
DateHeadline
Head to Head Review: Kadmon Holdings (KDMN) & Its PeersHead to Head Review: Kadmon Holdings (KDMN) & Its Peers
www.americanbankingnews.com - November 20 at 7:40 AM
Kadmon Holdings, Inc. (KDMN) Receives Consensus Recommendation of "Hold" from BrokeragesKadmon Holdings, Inc. (KDMN) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 19 at 8:04 PM
Kadmon Holdings (KDMN) versus Its Rivals Financial AnalysisKadmon Holdings (KDMN) versus Its Rivals Financial Analysis
www.americanbankingnews.com - November 19 at 3:28 PM
Head-To-Head Review: Auxilium Pharmaceuticals (AUXL) versus Kadmon Holdings (KDMN)Head-To-Head Review: Auxilium Pharmaceuticals (AUXL) versus Kadmon Holdings (KDMN)
www.americanbankingnews.com - November 17 at 2:08 PM
Kadmon Holdings, Inc. (KDMN) Given "Buy" Rating at HC WainwrightKadmon Holdings, Inc. (KDMN) Given "Buy" Rating at HC Wainwright
www.americanbankingnews.com - November 17 at 1:12 PM
Critical Review: Kadmon Holdings (KDMN) & Its PeersCritical Review: Kadmon Holdings (KDMN) & Its Peers
www.americanbankingnews.com - November 15 at 5:26 PM
Kadmon to Present at the Jefferies 2017 London Healthcare ConferenceKadmon to Present at the Jefferies 2017 London Healthcare Conference
finance.yahoo.com - November 15 at 3:45 AM
KADMON HOLDINGS, INC. Files SEC form 8-K, Other EventsKADMON HOLDINGS, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - September 30 at 6:01 PM

Social Media

Financials

Chart

Kadmon Holdings (NYSE KDMN) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.